SSR-482073

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameSSR-482073

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTranslocator protein modulators

TargetsTranslocator protein

Therapy Area/IndicationsCentral Nervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSanofi Aventis

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSanofi

Active IndicationsN/A

Inactive IndicationsCentral Nervous System Diseases

ATC CodeN/A